Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 4/20 | 0.63 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Dimethyl Ammonio Propane Sulfonate SCHEMBL28051649 | 0.98 | BBOX1 (0.61) | BBOX1DNM1HTTKMT2AHSP90AA1 | |
| SCHEMBL17912434 | 0.93 | BBOX1 (0.55) | BBOX1DNM1HTTKMT2AHSP90AA1 | |
| SCHEMBL918271 | 0.88 | BBOX1 (0.46) | BBOX1DNM1HTTAPPPTGS1 | |
| Sulfuric Acid SCHEMBL29054639 | 0.88 | BBOX1 (0.60) | BBOX1DNM1HTTKMT2AHSP90AA1 | |
| SCHEMBL1864397 | 0.84 | DNM1 (0.48) | BBOX1DNM1HTTKMT2AAPP | |
| SCHEMBL15382997 | 0.84 | DNM1 (0.50) | BBOX1DNM1HTTKMT2AHSP90AA1 | |
| Water SCHEMBL28532746 | 0.84 | BBOX1 (0.48) | BBOX1DNM1HTTKMT2AHSP90AA1 | |
| SCHEMBL22006989 | 0.84 | BBOX1 (0.43) | BBOX1DNM1HTTAPPPTGS1 | |
| Water SCHEMBL1271206 | 0.83 | DNM1 (0.46) | BBOX1DNM1HTTKMT2AAPP | |
| Mecetronium SCHEMBL330982 | 0.82 | DNM1 (0.63) | BBOX1DNM1HTTKMT2AHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388896-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | CELYNTRA THERAPEUTICS SA (BE) | 2025-12-25 | — | — | US | claimed |
| EP-4486881-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | Celyntra Therapeutics SA (BE) | 2025-01-08 | — | — | EP | claimed |
| US-11999817-B1 | Bismaleimide-thiol-epoxy polymer compositions, and methods of making and using the same | HRL LABORATORIES, LLC (US) | 2024-06-04 | — | — | US | claimed |
| WO-2023167882-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | ARTISAN DEVELOPMENT LABS, INC. (US) | 2023-09-07 | — | — | WO | claimed |
| WO-2019078655-A1 | COMPOSITION FOR INFILTRATING BIOMOLECULE INTO TISSUE INCLUDING SULFOBETAINE-BASED ZWITTERIONIC SURFACTANT, AND USE THEREOF | 재단법인대구경북과학기술원 | 2019-04-25 | — | — | WO | claimed |
| US-20180009840-A1 | ENHANCED FUNCTIONALITY AND DELIVERY OF A PROTEIN FROM A POROUS SUBSTRATE | BIO-RAD LABORATORIES, INC | 2018-01-11 | — | — | US | claimed |
| EP-3024843-A1 | ENHANCED FUNCTIONALITY AND DELIVERY OF A PROTEIN FROM A POROUS SUBSTRATE | Bio-Rad Laboratories, Inc. (US) | 2016-06-01 | — | — | EP | claimed |
| US-20150291874-A1 | METHODS FOR MAKING AND USING NOVEL FOAMER COMPOSITIONS | WEATHERFORD TECHNOLOGY HOLDINGS, LLC | 2015-10-15 | — | — | US | claimed |
| US-9018145-B2 | Foamer composition and methods for making and using same | Lubrizol Oilfield Solutions, Inc. (US) | 2015-04-28 | — | — | US | claimed |
| WO-2015013542-A1 | ENHANCED FUNCTIONALITY AND DELIVERY OF A PROTEIN FROM A POROUS SUBSTRATE | BIO-RAD LABORATORIES, INC. (US) | 2015-01-29 | — | — | WO | claimed |
| US-7906109-B2 | Pharmaceutical composition comprising an active principal and sulphobetaine | LEK PHARMACEUTICALS D.D. (SL) | 2011-03-15 | — | — | US | claimed |
| EP-1729794-B1 | A PHARMACEUTICAL COMPOSITION COMPRISING A NON-DETERGENT SULPHOBETAINE | LEK PHARMACEUTICALS (SI) | 2008-07-09 | — | — | EP | claimed |
| US-20070184019-A1 | Pharmaceutical composition comprising an active principal and sulphobetaine | LEK PHARMACEUTICALS D.D. (SI) | 2007-08-09 | — | — | US | claimed |
| EP-1729794-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PRINCIPLE AND SULPHOBETAINE | LEK Pharmaceuticals D.D. (SI) | 2006-12-13 | — | — | EP | claimed |
| US-20050250666-A1 | Foamer/sulfur scavenger composition and methods for making and using same | WEATHERFORD/LAMB, INC. | 2005-11-10 | — | — | US | claimed |
| WO-2005060989-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PRINCIPLE AND SULPHOBETAINE | LEK PHARMACEUTICALS D.D. (CH) | 2005-07-07 | — | — | WO | claimed |
| US-20050137114-A1 | environmentally friendly, biodegradable, nondepositing and high temperatures resistant aqueous foaming agents comprising a mixture of anionic, cationic and zwitterionic surfactants, used as drilling fluids | WEATHERFORD/LAMB, INC. | 2005-06-23 | — | — | US | claimed |
| WO-2005007895-A1 | METHODS AND KITS FOR OBTAINING NUCLEIC ACID FROM BIOLOGICAL SAMPLES | APPLERA CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| US-20050009036-A1 | Methods and kits for obtaining nucleic acid from biological samples | APPLERA CORPORATION (US) | 2005-01-13 | — | — | US | claimed |
| US-6471841-B1 | INCREASING ELECTROOSMOTIC FLOW; REDUCING ELECTROPHORETIC MOBILITY; EFFECTIVE CONCENTRATION OF 3-(N-ETHYL-N,N-DIMETHYL-AMMONIUM)PROPANESULFONATE; MICROFLUIDICS | CALIPER TECHNOLOGIES CORP. | 2002-10-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388896-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | GDA, XPA, ERCC2 | BBOX1 3065/4885DNM1 2445/4885HTT 190/4885 |
| US-20070184019-A1 | Pharmaceutical composition comprising an active principal and sulphobetaine | SCN2B, SCN1B, SPTSSB | BBOX1 1678/4885DNM1 1969/4885HTT 2094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.